Emoquine-1
Emoquine-1 is an orally active and potent antimalarial drug. Emoquine-1 is efficient against multidrug-resistant Plasmodium parasites, including the Artemisinin-resistant quiescent stage. Emoquine-1 is active against proliferative P. falciparum with IC50 values of 20-55 nM. Emoquine-1 is a candidate to fight Plasmodium parasites resistant to artemisinin-based combination therapies (ACTs) with a capacity to eliminate persistent parasites[1].
Product Specifications
UNSPSC
12352005
Target
Parasite
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
CC1=CC(C(C2=C3C(O)=CC(OCCOCCNCCNC4=CC=NC5=C4C=CC(Cl)=C5)=C2)=O)=C(C(O)=C1)C3=O
Molecular Formula
C30H28ClN3O6
Molecular Weight
562.01
References & Citations
[1]Youzhi Li, et al. Emoquine-1: A Hybrid Molecule Efficient against Multidrug-Resistant Plasmodium Parasites, Including the Artemisinin-Resistant Quiescent Stage, and Also Active In Vivo. J Med Chem. 2025 Jan 24.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A31819-FITC 100 µg/Vial
Anti-RTL3 Antibody Picoband®, FITC Conjugate
Sign In for Pricing
View Details 
036245-ML650 100 µL
GPR50, ID (GPR50, Melatonin-related receptor, G protein-coupled receptor 50, H9) (MaxLight 650) discontinued
Sign In for Pricing
View Details 
GTR15327313 1 Vial
Lentiviral human VCX2 shRNA (UAS) - Lentiviral human VCX2 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details